{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T04:29:17Z","timestamp":1697603357099},"reference-count":7,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T00:00:00Z","timestamp":1333497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1111\/j.1360-0443.2012.03842.x","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T08:16:31Z","timestamp":1333527391000},"page":"954-956","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["COUNSELLING DURING SUBSTITUTION TREATMENT: NOT ENOUGH IS TOO MUCH?"],"prefix":"10.1111","volume":"107","author":[{"given":"ADRIAN","family":"DUNLOP","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,4,4]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03700.x"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.1.102"},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.81.9.1185"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.01.008"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500150065028"},{"issue":"10","key":"e_1_2_3_7_2","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","author":"Amato L.","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_3_8_2","unstructured":"GreeneP.Outpatient drug utilization trends for buprenorphine years 2002\u20132009. Paper presented at the Buprenorphine Meeting 10\u201311 May2010 Washington D.C USA. Available fromhttp:\/\/buprenorphine.samhsa.gov\/meetings.html(accessed 28 March 2012)."}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2012.03842.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1360-0443.2012.03842.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T14:32:40Z","timestamp":1697553160000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2012.03842.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,4]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1111\/j.1360-0443.2012.03842.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2012.03842.x","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,4]]},"assertion":[{"value":"2012-04-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}